Biotech

All Articles

Gene editor Volume laying off 131 employees

.Merely times after gene editor Volume Biosciences announced concealed operational cuts, a more clea...

Repare gives up 25% of workers as biotech standstills preclinical R&ampD

.Repare Rehab is actually laying off an one-fourth of its own workforce as the oncology biotech scal...

J &amp J files for FDA authorization of $6.5 B autoimmune drug

.Johnson &amp Johnson has taken another action towards realizing a yield on its own $6.5 billion nip...

Gain's phase 1 succeed leads technique to verify Parkinson's drug's worth

.Gain Therapies has prepared its sights on proving the effectiveness of its own Parkinson's health c...

Actinogen files new phase 2 data to save anxiety drug

.Actinogen Medical's chances-- and inventory cost-- have rebounded somewhat from previously this mon...

Pfizer as well as Main incorporate Ratio to multibillion-dollar equation

.Flagship Pioneering and also Pfizer have actually added Quotient into their 10-program relationship...

Bayer pens $547M contract to drive borders of noncoding RNA

.Bayer executives were actually keen to worry to Strong this summertime that the German pharma giant...

UK reveals programs to release 18 brand new scientific test centers

.Among a yearslong clinical test decline in the U.K., a brand new public-private relationship has em...

UPDATE: Genentech telegraphs 93 unemployments in The golden state after sharing plans to shutter cancer cells immunology investigation system

.Observing the news of a big unemployment round in April and a significant restructuring initiative ...

Neurocrine's KarXT opponent attacks in period 2-- but simply at reduced dose

.Neurocrine Biosciences has obtained its hoped-for account in a phase 2 schizophrenia test, deliveri...